» zurück
Abdelsamie AS, Herath S, Biskupek Y, Börger C, Siebenbürger L, Salah M, Scheuer C, Marchais-Oberwinkler S, Frotscher M, Pohlemann T, Menger MD, Hartmann RW, Laschke MW, van Koppen CJ.
Targeted endocrine therapy: Design, synthesis, and proof-of-principle of 17β-hydroxysteroid dehydrogenase type 2 inhibitors in bone fracture healing.
J Med Chem. 2019;62:1362-72.
